Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 24Neoplasm Metastasis 3Neoplasms by Site 2Neoplasms 2Multiple Endocrine Neoplasia Type 1 2Breast Diseases 2Unilateral Breast Neoplasms 1Recurrence 1Osteitis Deformans 1Locally Advanced (Inoperable) or Metastatic Breast Cancer 1Hereditary Sensory and Autonomic Neuropathies 1HR+/HER2- Breast Cancer 1Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1Breast Neoplasms, Male 1Anatomic Stage II Breast Cancer AJCC v8 1Advanced Metastatic Breast Cancer 1Advanced Breast Cancer 1

Interventions

ribociclib 1Trastuzumab 1Paclitaxel 1Letrozole 1Lapatinib 1Goserelin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Osteitis Deformans × ribociclib × Clear all
NCT03096847 2021-10-11

Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer

Novartis

Phase 3 Completed
502 enrolled 20 charts
Breast

Breast Neoplasms, Osteitis Deformans

Data powered by HemOnc (CC BY 4.0) Colophon âš¡